Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Dougan

Showing results (71-80 of 145) with videos related to

Pageof 15
Sort By:
Journal of the American Academy of Dermatology|July 27, 2019
Prognostic implications of co-occurring dermatologic and gastrointestinal toxicity from immune checkpoint inhibition therapy for advanced malignancies: A retrospective cohort studyGabriel E Molina, Ian M Allen, Michael S Hughes, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2019
Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent miceYushu Joy Xie, Michael Dougan, Noor Jailkhani, et al.
Science Advances|November 24, 2023
DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunityRakeeb Kureshi, Elisa Bello, Courtney T S Kureshi, et al.
Nature Biotechnology|January 2, 2023
Facile repurposing of peptide-MHC-restricted antibodies for cancer immunotherapyXinbo Yang, Daisuke Nishimiya, Sara Löchte, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
SMAC mimetics induce human macrophages to phagocytose live cancer cellsSamantha Y Liu, Max Hulsman, Philipp Leyendecker, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
Immune checkpoint inhibitor-associated celiac diseaseYousef R Badran, Angela Shih, Donna Leet, et al.
The Journal of Experimental Medicine|September 15, 2010
IAP inhibitors enhance co-stimulation to promote tumor immunityMichael Dougan, Stephanie Dougan, Joanna Slisz, et al.
Immunotherapy Advances|August 4, 2025
SMAC mimetics induce human macrophages to phagocytose live cancer cellsSamantha Y Liu, Max P M Hulsman, Philipp Leyendecker, et al.
The Journal of Experimental Medicine|August 24, 2023
Correction: PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancerLestat R Ali, Ana C Garrido-Castro, Patrick J Lenehan, et al.
The Journal of Experimental Medicine|January 23, 2023
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancerLestat R Ali, Ana C Garrido-Castro, Patrick J Lenehan, et al.
Pageof 15

Showing results (71-80 of 145) with videos related to

Sort By:
Pageof 15
Journal of the American Academy of Dermatology|July 27, 2019
Prognostic implications of co-occurring dermatologic and gastrointestinal toxicity from immune checkpoint inhibition therapy for advanced malignancies: A retrospective cohort studyGabriel E Molina, Ian M Allen, Michael S Hughes, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2019
Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent miceYushu Joy Xie, Michael Dougan, Noor Jailkhani, et al.
Science Advances|November 24, 2023
DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunityRakeeb Kureshi, Elisa Bello, Courtney T S Kureshi, et al.
Nature Biotechnology|January 2, 2023
Facile repurposing of peptide-MHC-restricted antibodies for cancer immunotherapyXinbo Yang, Daisuke Nishimiya, Sara Löchte, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
SMAC mimetics induce human macrophages to phagocytose live cancer cellsSamantha Y Liu, Max Hulsman, Philipp Leyendecker, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
Immune checkpoint inhibitor-associated celiac diseaseYousef R Badran, Angela Shih, Donna Leet, et al.
The Journal of Experimental Medicine|September 15, 2010
IAP inhibitors enhance co-stimulation to promote tumor immunityMichael Dougan, Stephanie Dougan, Joanna Slisz, et al.
Immunotherapy Advances|August 4, 2025
SMAC mimetics induce human macrophages to phagocytose live cancer cellsSamantha Y Liu, Max P M Hulsman, Philipp Leyendecker, et al.
The Journal of Experimental Medicine|August 24, 2023
Correction: PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancerLestat R Ali, Ana C Garrido-Castro, Patrick J Lenehan, et al.
The Journal of Experimental Medicine|January 23, 2023
PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancerLestat R Ali, Ana C Garrido-Castro, Patrick J Lenehan, et al.
Pageof 15